Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 31-40 of 1772 for

Edit search filters
  1. Cancer Prevention: Stories For Change In Hispanic Community

    Rochester, MN

  2. Nanopore Sequencing For Detecting Bacteria In Bile And Preventing Surgical Site Infections In Patients Undergoing Surgery For Benign Or Malignant Pancreatic Tumors

    Rochester, MN

  3. A Safety And Efficacy Study Of Treatment Combinations With And Without Chemotherapy In Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  4. Study Of Ociperlimab In Combination With Tislelizumab In Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. Ketoconazole In Treating Participants With Ongoing EGFR Inhibitor-Induced Rash

    Rochester, MN

  6. Patient Satisfaction In Mohs Micrographic Surgery With Supplemental Lidocaine Jelly

    Scottsdale/Phoenix, AZ

  7. Brentuximab Vedotin And Nivolumab With Or Without Ipilimumab In Treating Patients With Relapsed Or Refractory Hodgkin Lymphoma

    Rochester, MN

  8. A Study To Evaluate Daratumumab And Ibrutinib To Treat Relapsed / Refractory Chronic Lymphocytic Leukemia Treatment (DIRECT)

    Jacksonville, FL

  9. A Study Evaluating The Efficacy Of Venetoclax Plus Ibrutinib In Subjects With T-cell Prolymphocytic Leukemia

    Rochester, MN

  10. A Study Of TAS-120 In Patients With Metastatic Breast Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer